Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hyperthermia and immunity. A brief overview.

Gianfranco Baronzio1, Alberto Gramaglia, Gianmaria Fiorentini

  • 1Radiotherapy Hyperthermia Department, Policlinico di Monza, Via Amati, 111, 20052, Italy. barongf@intercom.it

In Vivo (Athens, Greece)
|January 6, 2007
PubMed
Summary

Hyperthermia (HT) therapy is showing renewed promise, enhancing anti-tumour immunity by boosting dendritic cell activity. This approach improves immune cell trafficking and tumour cell recognition, offering a potential new cancer treatment strategy.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Selected Patients With Peritoneal Metastases From Breast Cancer May Benefit From Cytoreductive Surgery: The Results of a Multicenter Survey.

Frontiers in oncology·2022
Same author

Open radiofrequency ablation as upfront treatment for locally advanced pancreatic cancer: Requiem from a randomized controlled trial.

Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.]·2021
Same author

Almost one year of COVID-19 pandemic: how radiotherapy centers have counteracted its impact on cancer treatment in Lombardy, Italy. CODRAL/AIRO-L study.

Tumori·2021
Same author

Back to (new) normality-A CODRAL/AIRO-L survey on cancer radiotherapy in Lombardy during Italian COVID-19 phase 2.

Medical oncology (Northwood, London, England)·2020
Same author

Diagnostic and therapeutic algorithm for colorectal peritoneal metastases. A consensus of the peritoneal surface malignancies onco-team of the Italian society of surgical oncology.

European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·2020
Same author

Equipment, staffing, and provision of radiotherapy in Lombardy, Italy: Results of three surveys performed between 2012 and 2016.

Tumori·2018

Area of Science:

  • Oncology
  • Immunology
  • Thermotherapy

Background:

  • Hyperthermia (HT) is re-emerging as a significant cancer therapy, supported by recent positive clinical trial outcomes.
  • Tumour immunity is recognized as a crucial fourth pillar of treatment for metastatic cancers, including renal carcinoma and melanoma.

Purpose of the Study:

  • To review the biological and therapeutic effects of hyperthermia on immune cells and cytokines.
  • To explore the mechanisms by which hyperthermia enhances antigen presentation and dendritic cell activity.
  • To suggest the use of hyperthermia as an innate immunity booster in conjunction with biological response modifiers.

Main Methods:

  • Review of data from animal models and human patients regarding hyperthermia's effects on immunity.
  • Analysis of mechanisms including lymphocyte recruitment, tumour cell immunogenicity, and heat shock protein production.

Related Experiment Videos

  • Examination of hyperthermia's impact on dendritic cell stimulation.

    • Main Results:

    • Hyperthermia enhances antigen presentation and dendritic cell activity through multiple mechanisms.
    • Key mechanisms include increased lymphocyte recruitment, enhanced immunogenicity of heat-treated tumour cells, and boosted heat shock protein production.
    • Hyperthermia influences immune competent cells and cytokines, impacting tumour immunity.

    Conclusions:

    • Hyperthermia demonstrates significant effects on tumour immunity, particularly by enhancing dendritic cell function.
    • The study suggests combining hyperthermia with biological response modifiers to boost innate immunity.
    • Hyperthermia shows potential as an adjuvant therapy to improve outcomes in metastatic cancers like renal carcinoma and melanoma.